Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham, Massachusetts.
| Revenue (TTM) | $2.90B |
| Gross Profit (TTM) | $1.58B |
| EBITDA | $855.24M |
| Operating Margin | 12.40% |
| Return on Equity | 3.23% |
| Return on Assets | 2.27% |
| Revenue/Share (TTM) | $25.36 |
| Book Value | $64.20 |
| Price-to-Book | 1.51 |
| Price-to-Sales (TTM) | 3.73 |
| EV/Revenue | 4.584 |
| EV/EBITDA | 17.22 |
| Quarterly Earnings Growth (YoY) | 3.50% |
| Quarterly Revenue Growth (YoY) | 7.00% |
| Shares Outstanding | $111.56M |
| Float | $102.14M |
| % Insiders | 0.36% |
| % Institutions | 105.78% |
Volatility is currently contracting